MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    ProACT Study Protocol: a Randomized, Wait-list Controlled, Pragmatic Study on Parkinson’s Disease Multimodal Complex Treatment

    R. Scherbaum, E. Hinrichs, A. Horstmann, J. Schmidt-Fleischer, J. Stein, J. Geritz, J. Welzel, E. Kwon, J. Oppermann, V. Tschentscher, A. Mattukat, S. Muhlack, S. Faissner, C. Hansen, K. Winklhofer, R. Gold, W. Maetzler, N. Timmesfeld, L. Tönges (Bochum, Germany)

    Objective: To describe (1) the real-world effectiveness of the multidisciplinary inpatient rehabilitation (MIR) ‘Parkinson’s Disease Multimodal Complex Treatment’ (PD-MCT) in people with PD (PwP) compared…
  • 2024 International Congress

    Correlation between specific lower limb muscle strength and postural instability and gait difficulties in Parkinson’s disease

    M. van Emde-Boas, C. Pongmala, N. Bohnen (Ann Arbor, USA)

    Objective: To explore the relationship between the strength of specific lower limb musclegroups and their associations with PIGD motor features. Background: Postural instability and gait…
  • 2024 International Congress

    The Spatiotemporal Characteristics of Floor Sitting Rising in Parkinson’s Disease (PD)

    J. Alomar, D. Wani, T. Yu, S. Leung, L. Romero, S. El-Feky, J. Wong, K. Pu, L. Quinn (New York City, USA)

    Objective: To develop a method to characterize Floor Sitting Rising (FSR) in people with Parkinson disease (PwP). Background: Transitioning to the floor to a seated…
  • 2024 International Congress

    24 Hour Maxillofacial Administration of Levodopa in a Parkinsons Patient -An Alternative Route of Administration in Parkinsons Disease

    S. Thirunavukarasu, B. Ramanan, V. Varadharaj, TS. Suresh, KV. Verma, HAJ. Janardhanan, AUR. Ur (PUDUCHERRY, India)

    Objective: To assess tolerability, feasibility, safety and to assess outcome measures clinically as well as by serum levels over 24 hours, using the alternative maxillofacial…
  • 2024 International Congress

    Advancing regulatory endorsed drug development tools in alignment with emerging biology: The Critical Path for Parkinson’s Consortium

    D. Stephenson, C. Kopil, M. Müller, O. Mabrouk, H. Kocherla, R. Comley, K. Yee, T. Dam, G. Pagano, J. Seibyl, K. Marek, T. Simuni (Tucson, USA)

    Objective: To advance the regulatory maturity of drug development tools to support the newly proposed integrated staging of Neuronal Synuclein Disease (NSD-ISS) with focus on…
  • 2024 International Congress

    Multicentric Randomized Control Trial of Buspirone in Levodopa-Induced Dyskinesias

    H. Salhi, D. Maltête, S. Thobois, G. Fenelon, F. Ory, L. Defevre, G. Mangone, G. Defer, AR. Marques, S. Frismand, S. Drapier, JP. Azulay, C. Geny, G. Dupont, A. Doe-de-Maindreville, C. Barberot, D. Devos, JC. Corvol, O. Rascol, E. Audureau, P. Remy (Creteil, France)

    Objective: To investigate the efficacy of buspirone on levodopa induced dyskinesias (LID) in Parkinson disease (PD) patients Background: LID could be partially mediated by the…
  • 2024 International Congress

    A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

    J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…
  • 2024 International Congress

    Perceptions of Diseases in Patients with Cervical Dystonia

    D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, M. Patel, M. Moreno-Escobar, A. Murray, A. Memon, J. Frey (Morgantown, USA)

    Objective: To explore how perception of disease can impact stigma, mood, quality of life, and severity of symptoms in patients with cervical dystonia (CD). Background:…
  • 2024 International Congress

    The neural contributions to fear of falling avoidance behavior in Parkinson’s disease: preliminary evidence from a mobile neuroimaging paradigm

    C. Papantonatos, S. Carlson, YF. Chiu, N. Fritz, D. Peterson, J. Longhurst (Saint Louis, USA)

    Objective: The purpose of this study was to determine the relationship between fear of falling avoidance behavior (FFAB) and cortical hemodynamic response during dual-task (DT)…
  • 2024 International Congress

    Augmented feedback during virtual reality training improves learning in people with Parkinson’s disease: A Single-Blind Randomized Clinical Trial

    P. Igarasi Barbosa, A. Falconi, M. D'Alencar, E. Okamoto, M. Pimentel Piemonte (Sao Paulo, Brazil)

    Objective: This study aims to compare the effects of AF during VR training on motor learning in PPD. Background: Augmented feedback (AF) can enhance the learning…
  • « Previous Page
  • 1
  • …
  • 313
  • 314
  • 315
  • 316
  • 317
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley